1. Australia Stocks

  2. •

    Health technology

  3. •

    Biotechnology
Terragen Holdings Ltd

Terragen Holdings Ltd

AASX:TGH
0.01
AUD
+0.00
(-22.22%)
-0.01EPS
4.43MMarket Cap
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
- -
0.01
0.02
0.01
0.02
0.01
- -
Basic EPS, GAAP
- -
-0.03
-0.03
-0.03
-0.02
-0.01
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.11
0.09
0.07
0.04
0.02
0.01
- -
Tangible Book Value per Share
0.11
0.09
0.07
0.04
0.02
0.01
- -
Basic Weighted Avg Shares
188
152
190
194
196
348
438
Sales/Revenue/Turnover
- -
2
4
3
3
2
- -
Operating Margin (%)
- -
-385.98
-193.08
-220.62
-124.29
-185.73
- -
Depreciation Expense
- -
- -
1
1
- -
- -
- -
Net Income, GAAP
- -
-5
-6
-5
-3
-3
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
-321.76
-167.02
-187.05
-98.72
-141.04
- -
Working Capital
20
16
12
7
4
5
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
Total Equity
21
17
13
8
5
5
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-25.67
-40.58
-52.03
-50.38
-58.01
- -

Capital Structure

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

AUD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
3
2024
- -
- -
2
2025
- -
- -
- -

Semi-annual Earnings Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.02
2024
- -
- -
-0.01
2025
- -
- -
- -

Semi-annual Dividends Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Richard Norton
Full Time Employees
15
Sector
Health technology
Industry
Biotechnology
Address
39 Access Crescent Coolum Beach QLD Australia 4573
IPO Date
Dec 11, 2019
Website
terragen.com.au
Similar Companies
Moderna, Inc. (NASDAQ:MRNA)
Amgen Inc. (NASDAQ:AMGN)
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Novavax, Inc. (NASDAQ:NVAX)
10x Genomics, Inc. (NASDAQ:TXG)
Business
Terragen Holdings Limited (ASX:TGH), founded in 1996 and headquartered in Coolum Beach, Queensland, Australia, develops, manufactures, and commercializes biological products utilizing microbial technology for the agriculture sector; its core offerings include animal feed supplements such as MYLO, MYLO Calf, and MYLO Cow, which enhance feed conversion, animal health, fertility, milk production, and methane reduction in beef, dairy, calf, and lamb applications; and soil conditioners like Great Land Plus and Terragen Probiotic for Ruminants, which improve soil microbiome, nutrient availability, plant growth, pasture quality, and stress resistance without chemical fertilizers, pesticides, or antibiotics. The company operates primarily in Australia and New Zealand, targeting livestock producers, dairy farmers, and crop growers with sustainable bio-solutions focused on animal wellbeing, soil health, and productivity. Recent developments include the granting of a US patent in July 2025 for its microbial feed supplement technology; receipt of a A$989,242 R&D tax incentive from the Australian Taxation Office for the 2024/2025 financial year to bolster innovation efforts; release of the 2025 AGM presentation and investor update in November 2025 highlighting trial results such as 4.6% increased average daily weight gain in beef feedlots and 30% methane intensity reduction in lambs; and a 24% revenue decline to A$911,597 in the latest half-year report amid ongoing product commercialization and research expansion.